Christopher Redfern

Default user avatar

Newcastle University
Newcastle Cancer Centre
Paul O'Gorman Building
Newcastle Upon Tyne
NE2 4HH
United Kingdom

Email: chris.redfern@ncl.ac.uk
Tel: 0191 246 4416
Web: Lab website

Christopher Redfern other research projects

Funding period: 01 October 2008 to 30 September 2012

Recent publications


Combining the Endoplasmic Reticulum Stress-Inducing Agents Bortezomib and Fenretinide as a Novel Therapeutic Strategy for Metastatic Melanoma

Clin Cancer Res.2009;15 :1192-1198

Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: the role of stress proteins ERdj5 and ERp57

Br J Cancer.2007;96 :1062-1071